drugset / Trial / NCT06981845
Sirolimus With corTicOsteroid TheraPy for Rapid rEcurrences of Coronary Unexplained In-stent Restenosis
Not yet recruiting
52 enrolled
China National Center for Cardiovascular Diseases
Chinese Academy of Medical Sciences, Fuwai Hospital · collabThe First Hospital of Jilin University · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study aims to evaluate, through a multicenter, prospective, double-blind, randomized, placebo-controlled clinical trial, whether immunosuppressive therapy improves target lesion-related cardiovascular outcomes compared to placebo treatment in patients with Rapid rEcurrence of Coronary Unexplained in-stent Restenosis (RECUR).
Timeline
- Start
- 2025-06-01
- Primary completion
- 2028-06-01
- Completion
- 2028-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Prednisone | Other / unclassified | — | — |
| Subject | Sirolimus | Small molecule | — | — |